AR061046A1 - MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN - Google Patents

MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN

Info

Publication number
AR061046A1
AR061046A1 ARP070102181A ARP070102181A AR061046A1 AR 061046 A1 AR061046 A1 AR 061046A1 AR P070102181 A ARP070102181 A AR P070102181A AR P070102181 A ARP070102181 A AR P070102181A AR 061046 A1 AR061046 A1 AR 061046A1
Authority
AR
Argentina
Prior art keywords
treatment
neuropathic pain
mirtazapine
medicament
administering
Prior art date
Application number
ARP070102181A
Other languages
Spanish (es)
Inventor
Gerardus Stephanus Franc Ruigt
Andrea Houghton
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of AR061046A1 publication Critical patent/AR061046A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Método de tratamiento del dolor neuropático que comprende administrar a un sujeto que necesita tratamiento para el dolor neuropático, una dosis terapéuticamente eficaz de S(+)-mirtazapina, y uso de S(+)mirtazapina para la fabricacion de un medicamento para el tratamiento del dolor neuropático, y composicion farmacéutica para el tratamiento del dolor neuropático, que comprende S(+)-mirtazapina.Neuropathic pain treatment method comprising administering to a subject in need of treatment for neuropathic pain, a therapeutically effective dose of S (+) - mirtazapine, and use of S (+) mirtazapine for the manufacture of a medicament for the treatment of neuropathic pain, and pharmaceutical composition for the treatment of neuropathic pain, comprising S (+) - mirtazapine.

ARP070102181A 2006-05-22 2007-05-21 MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN AR061046A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06114316 2006-05-22

Publications (1)

Publication Number Publication Date
AR061046A1 true AR061046A1 (en) 2008-07-30

Family

ID=37006417

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102181A AR061046A1 (en) 2006-05-22 2007-05-21 MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN

Country Status (8)

Country Link
EP (1) EP2026814A2 (en)
JP (1) JP2009537601A (en)
AR (1) AR061046A1 (en)
CA (1) CA2651607A1 (en)
MX (1) MX2008014287A (en)
PE (1) PE20080455A1 (en)
TW (1) TW200808804A (en)
WO (1) WO2007135123A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452954B2 (en) * 2013-05-16 2019-01-16 国立大学法人千葉大学 Cancer metastasis inhibitor
AU2016222550B2 (en) 2015-02-27 2020-07-16 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6835728B2 (en) * 2000-01-19 2004-12-28 Akzo Nobel N.V. Drug combination for the treatment of depression and related disorders comprising mirtazapine
US7074961B2 (en) * 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
UA83666C2 (en) * 2003-07-10 2008-08-11 Н.В. Органон Method for the preparation of enantiomerically pure mirtazapine
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
WO2007135123A2 (en) 2007-11-29
PE20080455A1 (en) 2008-06-25
TW200808804A (en) 2008-02-16
WO2007135123A3 (en) 2008-03-13
MX2008014287A (en) 2008-11-18
CA2651607A1 (en) 2007-11-29
JP2009537601A (en) 2009-10-29
EP2026814A2 (en) 2009-02-25

Similar Documents

Publication Publication Date Title
CL2011002858A1 (en) Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain.
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
CL2011000935A1 (en) Pharmaceutical composition comprising acetaminophen and a complex tramadol material, which exhibits a sustained and coordinated release through a sustained release and an immediate release layer; method of preparation; and the use of a complex material of tramadol and acetaminophen to prepare a medication for the treatment of pain.
AR065579A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
EA201300121A1 (en) DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PREPARATION
CO6160321A2 (en) USE OF 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PYRIMIDIN-1-ILMETIL-4-FLUORO-BENZONITRILE
MX2009003372A (en) Non-mucoadhesive film dosage forms.
AR060836A1 (en) A TRANS-MUCOSA DISK TO ADMINISTER AN ACTIVE AGENT, A TRANS-MUCOSA COMPOSITION AND THE METHOD OF ADMINISTRATION OBTAINED
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
AR062522A1 (en) TREATMENT OF DISORDERS IN CARTILAGOS
ECSP21051833A (en) COMBINATION OF DEXTROMETORPHAN AND BUPROPION FOR THE TREATMENT OF DEPRESSION
AR065580A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
CO6220969A2 (en) WEEKLY ADMINSITRATION OF DIPEPTIDILO PEPTIDASE INHIBITORS
UY30158A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT
AR065581A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
AR089509A1 (en) METHOD FOR TREATING LOSS OSEA ALVEOLAR, A DENTAL IMPLANT, AN ANTIBODYCEROSTIN ANTIBODY, A GEL OR MATRIX THAT INCLUDES SUCH ANTIBODY AND USE
CO6771406A2 (en) A combined composition
MX2009011900A (en) Diabetic wound healing.
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
CL2009001841A1 (en) Use of a sustained release composition of 4-aminopyridine to prepare a medicament useful for treating multiple sclerosis in a subject.
AR065582A1 (en) IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME
AR065139A1 (en) MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS
ECSP10010567A (en) Use of dronedarone to prepare a medication for the treatment of patients with arrhythmia and who have an increase in creatinine level due to the administration of dronedarone
PE20130147A1 (en) PHARMACEUTICAL COMBINATION OF THEOBROMINE AND A NON-OPIOID ANTITUSSIVE AGENT
CL2008000965A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN OPIACEAL ANALGESIC, AND ITS USE FOR PAIN TREATMENT.

Legal Events

Date Code Title Description
FB Suspension of granting procedure